Anupam Rasayan India growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+64.6%−2.6%−7.9%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+30.9%+5.3%−11.8%
+28.9%−0.8%−16.5%
+38.9%−4.5%−22.8%
+77.5%−28.5%−43.1%
+52.1%+14.5%+21.8%
+50.2%+5.2%+16.8%
+1,209.8%−151.0%−79.8%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ANURAS₹1,182.00

Anupam Rasayan India Ltd.

· Chemicals
₹ CrorePeersAETHERPIINDATULSHKBAYERCROPSWANCORPCAMLINFINECLEANMcap ₹13,457 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—-7.9-2.6+64.6—
EBITDA Growth—-11.8+5.3+30.9—
EBIT Growth—-16.5-0.8+28.9—
Net Income Growth—-22.8-4.5+38.9—
EPS Growth—-43.1-28.5+77.5—
Total Assets Growth—+21.8+14.5+52.1—
Total Equity Growth—+16.8+5.2+50.2—
Cash from Operations Growth—-79.8-151.0+1,209.8—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.